| Target Price | $135.66 |
| Price | $95.11 |
| Potential | 42.63% |
| Number of Estimates | 28 |
| 28 Analysts have issued a price target Cisco 2027 . The average Cisco target price is $135.66. This is 42.63% higher than the current stock price. The highest price target is $173.25 82.16% , the lowest is $88.88 6.55% . | |
| A rating was issued by 35 analysts: 23 Analysts recommend Cisco to buy, 12 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Cisco stock has an average upside potential 2027 of 42.63% . Most analysts recommend the Cisco stock at Purchase. |
30 Analysts have issued a sales forecast Cisco 2027 . The average Cisco sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
21 Analysts have issued an Cisco EBITDA forecast 2027. The average Cisco EBITDA estimate is
. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .This results in the following potential growth metrics and future EBITDA Margins:
30 Cisco Analysts have issued a net profit forecast 2027. The average Cisco net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | Nov 13 2026 |
| Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Nov 13 2026 |
| Citigroup |
Buy
➜
Buy
|
Unchanged | Nov 13 2026 |
| Truist Securities |
Buy
➜
Buy
|
Unchanged | Nov 13 2026 |
| Piper Sandler |
Neutral
➜
Neutral
|
Unchanged | Nov 13 2026 |
| Rosenblatt |
Buy
➜
Buy
|
Unchanged | Nov 13 2026 |
| Morgan Stanley |
Overweight
➜
Equal-Weight
|
Downgrade | Nov 05 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
Nov 13 2026 |
|
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Nov 13 2026 |
|
Unchanged
Citigroup:
Buy
➜
Buy
|
Nov 13 2026 |
|
Unchanged
Truist Securities:
Buy
➜
Buy
|
Nov 13 2026 |
|
Unchanged
Piper Sandler:
Neutral
➜
Neutral
|
Nov 13 2026 |
|
Unchanged
Rosenblatt:
Buy
➜
Buy
|
Nov 13 2026 |
|
Downgrade
Morgan Stanley:
Overweight
➜
Equal-Weight
|
Nov 05 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


